California State Teachers Retirement System (CalSTRS)’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
Other funds holding ABCL
BBA
CS
O
ACH
FFVM
California State Teachers Retirement System (CalSTRS)'s ABCL Position: Q2 2023 in Review
California State Teachers Retirement System (CalSTRS) sold out of AbCellera Biologics (ABCL) in Q2 2023, closing a stake of 77,052 shares — an estimated $581K sold.
California State Teachers Retirement System (CalSTRS) first reported a position in ABCL in Q3 2021 and held it in 7 quarters. The position peaked at $1.01M in Q2 2022. 169 funds tracked by Wall St. Rank hold ABCL as of Q2 2023.
- California State Teachers Retirement System (CalSTRS) reported no remaining AbCellera Biologics position as of Q2 2023 after selling out during the quarter.
- California State Teachers Retirement System (CalSTRS) sold 77,052 AbCellera Biologics shares in Q2 2023, an estimated $581K.
- California State Teachers Retirement System (CalSTRS) first reported a position in AbCellera Biologics in Q3 2021 and held it in 7 quarters.
- California State Teachers Retirement System (CalSTRS)'s AbCellera Biologics position peaked at $1.01M in Q2 2022.
- 169 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2023.
Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2023, filed 21 Aug 2023.